Coloplast A/S (CPH:COLO.B)
Denmark · Delayed Price · Currency is DKK 551.40
+0.80 (0.15%)
Sep 29, 2025, 4:59 PM CET
Coloplast Revenue
Coloplast had revenue of 6.96B DKK in the quarter ending June 30, 2025, with 1.06% growth. This brings the company's revenue in the last twelve months to 27.87B, up 5.95% year-over-year. In the fiscal year ending September 30, 2024, Coloplast had annual revenue of 27.03B with 10.33% growth.
Revenue (ttm)
27.87B
Revenue Growth
+5.95%
P/S Ratio
4.45
Revenue / Employee
1.66M
Employees
16,639
Market Cap
123.98B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 27.03B | 2.53B | 10.33% |
| Sep 30, 2023 | 24.50B | 1.92B | 8.51% |
| Sep 30, 2022 | 22.58B | 3.15B | 16.23% |
| Sep 30, 2021 | 19.43B | 882.00M | 4.76% |
| Sep 30, 2020 | 18.54B | 605.00M | 3.37% |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 311.94B |
| Genmab | 23.16B |
| Demant | 22.59B |
| ALK-Abelló | 5.86B |
| H. Lundbeck | 23.52B |
| Zealand Pharma | 9.11B |
| Ambu A/S | 5.96B |
| Bavarian Nordic | 6.46B |
Coloplast News
- 26 days ago - Coloplast A/S (CLPBY) Capital Markets Day 2025 Transcript - Seeking Alpha
- 27 days ago - Coloplast A/S - Coloplast presents new 5-year strategy, Impact4 - GlobeNewsWire
- 27 days ago - Coloplast A/S - Announcement no. 07/2025 - Coloplast announces new financial ambition towards 2030 - GlobeNewsWire
- 5 weeks ago - Coloplast A/S (CLPBF) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Coloplast A/S - Interim Financial Report, 9M 2024/25 - GlobeNewsWire
- 5 weeks ago - Coloplast A/S – Updated presenters list for Capital Markets Day on 2 September 2025 - GlobeNewsWire
- 5 weeks ago - Coloplast A/S Non-GAAP EPS of DKK 3.86, revenue of DKK 6.96B; reaffirms FY outlook - Seeking Alpha
- 5 weeks ago - Coloplast A/S - Interim Financial Report, 9M 2024/25 - GlobeNewsWire